Qiagen NV (QGEN)
41.86
-0.03
(-0.07%)
USD |
NYSE |
Jun 21, 16:00
41.85
-0.01
(-0.02%)
Pre-Market: 20:00
Qiagen Cash from Operations (Quarterly): 133.08M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 133.08M |
| December 31, 2023 | 151.37M |
| September 30, 2023 | 124.68M |
| June 30, 2023 | 111.48M |
| March 31, 2023 | 71.93M |
| December 31, 2022 | 124.32M |
| September 30, 2022 | 211.58M |
| June 30, 2022 | 171.95M |
| March 31, 2022 | 207.41M |
| December 31, 2021 | 198.46M |
| September 30, 2021 | 155.52M |
| June 30, 2021 | 156.40M |
| March 31, 2021 | 128.63M |
| December 31, 2020 | 269.71M |
| September 30, 2020 | 37.50M |
| June 30, 2020 | 134.68M |
| March 31, 2020 | 15.91M |
| December 31, 2019 | 109.43M |
| September 30, 2019 | 94.20M |
| June 30, 2019 | 82.48M |
| March 31, 2019 | 44.73M |
| December 31, 2018 | 110.51M |
| September 30, 2018 | 82.75M |
| June 30, 2018 | 118.02M |
| March 31, 2018 | 48.22M |
| Date | Value |
|---|---|
| December 31, 2017 | 76.07M |
| September 30, 2017 | 81.20M |
| June 30, 2017 | 69.36M |
| March 31, 2017 | 60.16M |
| December 31, 2016 | 100.02M |
| September 30, 2016 | 93.81M |
| June 30, 2016 | 99.08M |
| March 31, 2016 | 48.69M |
| December 31, 2015 | 86.76M |
| September 30, 2015 | 96.06M |
| June 30, 2015 | 71.83M |
| March 31, 2015 | 62.84M |
| December 31, 2014 | 79.02M |
| September 30, 2014 | 89.73M |
| June 30, 2014 | 73.60M |
| March 31, 2014 | 45.61M |
| December 31, 2013 | 82.19M |
| September 30, 2013 | 82.94M |
| June 30, 2013 | 47.96M |
| March 31, 2013 | 45.88M |
| December 31, 2012 | 69.91M |
| September 30, 2012 | 74.93M |
| June 30, 2012 | 88.92M |
| March 31, 2012 | 11.12M |
| December 31, 2011 | 79.68M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
15.91M
Minimum
Mar 2020
269.71M
Maximum
Dec 2020
134.54M
Average
130.85M
Median
Cash from Operations (Quarterly) Benchmarks
| MoonLake Immunotherapeutics | -14.95M |
| LENZ Therapeutics Inc | -23.94M |
| Thermo Fisher Scientific Inc | 1.251B |
| argenx SE | -- |
| uniQure NV | -60.58M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 6.431M |
| Cash from Financing (Quarterly) | -292.09M |
| Free Cash Flow | 357.85M |
| Free Cash Flow Per Share (Quarterly) | 0.418 |
| Free Cash Flow to Equity (Quarterly) | 101.18M |
| Free Cash Flow to Firm (Quarterly) | 94.72M |
| Free Cash Flow Yield | 3.81% |